TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11902739

Group type: COMPARATOR
Intervention: 10 mL/kg red blood cells
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 20 mL/kg red blood cells
Number of subjects: 0
Study: 9820444

Group type: EXPERIMENTAL
Intervention: Silver ring device
Number of subjects: 195

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 195
Study: 7714065

Group type: EXPERIMENTAL
Intervention: 400 IU vitamin D3 per day
Number of subjects: 348

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 348
Study: 2523785

Group type: EXPERIMENTAL
Intervention: NPH insulin (12 units injected subcutaneously)
Number of subjects: 6
Study: 414344

Group type: EXPERIMENTAL
Intervention: Floctafenine 1.6 g daily
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Soluble aspirin 4.0 g daily
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Floctafenine 1.6 g daily for 3-6 months
Number of subjects: 48
Study: 29298622

Group type: EXPERIMENTAL
Intervention: CoQ10 (400 mg/day)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo (wheat starch)
Number of subjects: 45
Study: 28879245

Group type: EXPERIMENTAL
Intervention: 8% capsaicin cream
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 0
Study: 26237980

Group type: EXPERIMENTAL
Intervention: Herbal medicine + auricular pressure (treatment group)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Chinese herbal medicine (control group)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Both groups (treatment and control)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Treatment group
Number of subjects: 66
Study: 24139639

Group type: EXPERIMENTAL
Intervention: Daily oral pre-exposure prophylaxis (PrEP) for HIV prevention
Number of subjects: 3163
Study: 21504351

Group type: EXPERIMENTAL
Intervention: Talking to friends about asthma
Number of subjects: 835

Group type: EXPERIMENTAL
Intervention: Worry, concern, or trouble about asthma
Number of subjects: 835

Group type: EXPERIMENTAL
Intervention: Emotional quality of life
Number of subjects: 835
Study: 19706240

Group type: EXPERIMENTAL
Intervention: Celecoxib (selective COX-2 inhibitor) for 1 week
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 40
Study: 16773176

Group type: EXPERIMENTAL
Intervention: Skin prick test for B. germanica
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Skin prick test for P. americana
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Specific IgE for B. germanica
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Specific IgE for P. americana
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Total IgE levels
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Skin prick test and specific IgE correlation
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Cockroach-specific IgE
Number of subjects: 118
Study: 15313938

Group type: EXPERIMENTAL
Intervention: Disease Management (DM) for 90 days
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study: 10717011

Group type: EXPERIMENTAL
Intervention: Etanercept (0.4 mg/kg subcutaneously twice weekly for up to three months)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Etanercept (in double-blind study)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo (in double-blind study)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Etanercept and Placebo
Number of subjects: 69
Study: 9113213

Group type: EXPERIMENTAL
Intervention: Alcohol rehabilitation program treatment
Number of subjects: 74

Group type: COMPARATOR
Intervention: Comparison group for practice effects
Number of subjects: 74
Study: 8111484

Group type: EXPERIMENTAL
Intervention: Fenfluramine and mazindol (combined)
Number of subjects: 1163

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1163

Group type: EXPERIMENTAL
Intervention: Mazindol
Number of subjects: 1163
Study: 2870226

Group type: EXPERIMENTAL
Intervention: SMS 201-995, 50 micrograms/h, continuous intravenous infusion
Number of subjects: 10
Study: 2975549

Group type: EXPERIMENTAL
Intervention: Glibenclamide
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Glibenclamide and Metformin
Number of subjects: 35
Study: 31454829

Group type: EXPERIMENTAL
Intervention: AKI risk alerts intervention
Number of subjects: 3006

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3006
Study: 31021944

Group type: EXPERIMENTAL
Intervention: McNamara education program (experimental group)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 70
Study: 28475456

Group type: EXPERIMENTAL
Intervention: Oral brigatinib 90 mg once daily (arm A)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Oral brigatinib 180 mg once daily with a 7-day lead-in at 90 mg (arm B)
Number of subjects: 222
Study: 26145274

Group type: EXPERIMENTAL
Intervention: Taxes on low nutrient dense foods (e.g. sweetened beverages, candy, salty snacks)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Subsidies on fruits, vegetables, and bottled water (12.5% or 25%)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Taxes on grains
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Subsidies on grains
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Subsidies on miscellaneous foods
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Subsidies on foods purchased
Number of subjects: 199
Study: 23276359

Group type: EXPERIMENTAL
Intervention: Hybrid constructs (artificial disk replacement combined with midlevel ACDF)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 3-level ACDF
Number of subjects: 24
Study: 21477037

Group type: EXPERIMENTAL
Intervention: Quartz-tungsten-halogen (QTH) - 450 mW/cm²
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Laser (LAS) - 300 mW/cm²
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Second-generation light-emitting diode (LED 2) - 1100 mW/cm²
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Third generation LED - 700 mW/cm²
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Whisky
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Red wine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Distilled water
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cola
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Coffee
Number of subjects: 50
Study: 18679669

Group type: EXPERIMENTAL
Intervention: Nebicapone 200 mg thrice daily for 9 days with racemic warfarin 25 mg single dose on day 4
Number of subjects: 16

Group type: COMPARATOR
Intervention: Racemic warfarin 25 mg single dose alone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Nebicapone
Number of subjects: 16
Study: 16434127

Group type: EXPERIMENTAL
Intervention: RTS,S/AS02A
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: MVA-CS
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Heterologous prime-boost (RTS,S followed by MVA-CS)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Heterologous prime-boost (MVA-CS followed by RTS,S)
Number of subjects: 18
Study: 14646973

Group type: EXPERIMENTAL
Intervention: Positive anticardiolipin antibody (ACLA) levels in adolescents in the case group (parents with MI<55 years)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Positive anticardiolipin antibody (ACLA) levels in parents of adolescents in the case group (parents with MI<55 years)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Correlation of positive ACLA between parents with premature MI and their children
Number of subjects: 150
Study: 10715297

Group type: EXPERIMENTAL
Intervention: Vancomycin/Heparin/Ciprofloxacin flush solution (VHC)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Vancomycin/Heparin (VH)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Heparin alone
Number of subjects: 126
Study: 9361168

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg once daily
Number of subjects: 509

Group type: EXPERIMENTAL
Intervention: Omeprazole 10 mg once daily
Number of subjects: 509

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 509
Study: 1546824

Group type: EXPERIMENTAL
Intervention: Laser skin testing
Number of subjects: 20

Group type: COMPARATOR
Intervention: Puncture testing with Morrow‐Brown Needle
Number of subjects: 20
Study: 3982273

Group type: EXPERIMENTAL
Intervention: Caffeine (400 mg added to decaffeinated coffee)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Decaffeinated coffee (control)
Number of subjects: 9
Study: 29623447

Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted lopinavir (LPV/r) based antiretroviral therapy (ART)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Efavirenz-based ART
Number of subjects: 219

Group type: COMPARATOR
Intervention: HIV-infected children (both ART groups)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: HIV-infected children on LPV/r
Number of subjects: 219
Study: 27029920

Group type: COMPARATOR
Intervention: Standard therapy (vancomycin or daptomycin)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Standard therapy plus 7 days of an anti‐staphylococcal β‐lactam (flucloxacillin, cloxacillin, or cefazolin)
Number of subjects: 440
Study: 24496567

Group type: EXPERIMENTAL
Intervention: SL-OCT imaging
Number of subjects: 40
Study: 22959512

Group type: EXPERIMENTAL
Intervention: Grouping of two rams in a neutral pen
Number of subjects: 12
Study: 20351334

Group type: EXPERIMENTAL
Intervention: vinflunine 320 mg/m² every 21 days
Number of subjects: 551

Group type: COMPARATOR
Intervention: docetaxel 75 mg/m² every 21 days
Number of subjects: 551
Study: 18261667

Group type: EXPERIMENTAL
Intervention: Sonography
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Nerve conduction study (NCS)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Comparison of sonography and NCS
Number of subjects: 29

Group type: COMPARATOR
Intervention: Cross-sectional area (CSA) measurement
Number of subjects: 29
Study: 17273677

Group type: EXPERIMENTAL
Intervention: Digital retinographer injecting 2 ml fluorescein at 10%
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional retinographer injecting 5 ml sodium fluorescein at 10%
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Both groups (control and study)
Number of subjects: 70
Study: 11896774

Group type: EXPERIMENTAL
Intervention: Topical vitamin C preparation (10% ascorbic acid and 7% tetrahexyldecyl ascorbate in polysilicone gel)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Inactive polysilicone gel base (control)
Number of subjects: 10
Study: 10776116

Group type: EXPERIMENTAL
Intervention: Educational materials, counseling, special evening clinics, reminders of scheduled Pap appointments
Number of subjects: 481

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 481
Study: 7824129

Group type: EXPERIMENTAL
Intervention: MRI criteria for MS
Number of subjects: 36
Study: 2362094

Group type: EXPERIMENTAL
Intervention: Chronic beta-carotene supplementation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 6777178

Group type: EXPERIMENTAL
Intervention: Procainamide
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tocainide
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tocainide 400 mg every 8 h
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tocainide (after 6 months treatment)
Number of subjects: 10
Study: 29925316

Group type: EXPERIMENTAL
Intervention: Propofol anesthesia
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sevoflurane anesthesia
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study: 27026059

Group type: EXPERIMENTAL
Intervention: Avocado-soybean unsaponifiable extract (ASU)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 24356474

Group type: EXPERIMENTAL
Intervention: ETN + MTX
Number of subjects: 423

Group type: COMPARATOR
Intervention: DMARD + MTX
Number of subjects: 423
Study: 21492237

Group type: EXPERIMENTAL
Intervention: Implant treatment in patients with OLP
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (non-OLP patients)
Number of subjects: 36
Study: 20497755

Group type: EXPERIMENTAL
Intervention: Etanercept (TNF-alpha receptor antagonist), administered twice weekly for 44 weeks
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 17362422

Group type: EXPERIMENTAL
Intervention: Porcelain inlays cemented with dental adhesive and composite resin cement
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no restorations)
Number of subjects: 32
Study: 15751771

Group type: EXPERIMENTAL
Intervention: rosiglitazone 4 mg, twice daily
Number of subjects: 64

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 64
Study: 12192016

Group type: EXPERIMENTAL
Intervention: Total mastectomy with radiation
Number of subjects: 1665

Group type: EXPERIMENTAL
Intervention: Total mastectomy without radiation
Number of subjects: 1665

Group type: EXPERIMENTAL
Intervention: Total mastectomy with radiation (positive nodes)
Number of subjects: 1665

Group type: COMPARATOR
Intervention: Radical mastectomy
Number of subjects: 1665
Study: 9571600

Group type: EXPERIMENTAL
Intervention: Percutaneous estradiol (pE2) 1.5 mg/day
Number of subjects: 43

Group type: COMPARATOR
Intervention: Oral estriol (E3) 2 mg/day
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Percutaneous estradiol (pE2) 1.5 mg/day (3rd year follow-up)
Number of subjects: 43
Study: 7803550

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 2846947

Group type: EXPERIMENTAL
Intervention: Nitrendipine
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Mepindolol
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 299
Study: 28847792

Group type: EXPERIMENTAL
Intervention: Methylprednisolone pulse therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 28735847

Group type: EXPERIMENTAL
Intervention: Active TENS
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 37
Study: 25836006

Group type: EXPERIMENTAL
Intervention: Microimplant anchorage
Number of subjects: 31

Group type: COMPARATOR
Intervention: Headgear anchorage
Number of subjects: 31
Study: 24579474

Group type: EXPERIMENTAL
Intervention: BIFICO therapy for 4 consecutive days
Number of subjects: 490

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 490
Study: 21689897

Group type: EXPERIMENTAL
Intervention: Group drug counseling
Number of subjects: 438
Study: 20078008

Group type: EXPERIMENTAL
Intervention: Decreased total sleep time (TST)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Fewer respiratory awakenings
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Higher oxygen saturation (SaO(2)) nadir
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Decreased TST
Number of subjects: 90
Study: 17027149

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) training for 5 weeks, consisting of 15 sessions of isometric NMES.
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) training for 5 weeks.
Number of subjects: 19
Study: 14559889

Group type: COMPARATOR
Intervention: Government-sponsored trial
Number of subjects: 20

Group type: COMPARATOR
Intervention: Pharmaceutical industry-sponsored trial
Number of subjects: 20

Group type: COMPARATOR
Intervention: Industry-sponsored trial
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nonclinical activities
Number of subjects: 20
Study: 11127853

Group type: EXPERIMENTAL
Intervention: STA Liatest D‐dimer
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: MDA D‐dimer
Number of subjects: 123

Group type: COMPARATOR
Intervention: VIDAS D‐dimer (reference method)
Number of subjects: 123
Study: 9344305

Group type: EXPERIMENTAL
Intervention: Auditory sensory feedback during treadmill walking at speeds of 1, 2, and 2.5 mph.
Number of subjects: 50
Study: 7981178

Group type: EXPERIMENTAL
Intervention: lovastatin 40 mg twice daily
Number of subjects: 63

Group type: COMPARATOR
Intervention: matching placebo tablets twice daily
Number of subjects: 63
Study: 2725184

Group type: COMPARATOR
Intervention: 10 ug/kg atropine intravenously
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 10 ug/kg atropine endotracheally
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 20 ug/kg atropine endotracheally
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 30 ug/kg atropine endotracheally
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 40 ug/kg atropine endotracheally
Number of subjects: 50
Study: 4570671

Group type: EXPERIMENTAL
Intervention: Verapamil (120 mg thrice daily)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Propranolol (100 mg thrice daily)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (20 mg thrice daily)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 30219958

Group type: EXPERIMENTAL
Intervention: Other-focus perspective setting
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Self-focus perspective setting
Number of subjects: 2

Group type: COMPARATOR
Intervention: Baseline perspective setting
Number of subjects: 2
Study: 28267354

Group type: EXPERIMENTAL
Intervention: Body size-specific organ and effective doses calculated using the National Cancer Institute CT (NCICT) dosimetry program.
Number of subjects: 23734

Group type: COMPARATOR
Intervention: Reference phantom-based dose calculation.
Number of subjects: 23734

Group type: EXPERIMENTAL
Intervention: Effective dose calculations for body size-specific groups.
Number of subjects: 23734
Study: 25344736

Group type: EXPERIMENTAL
Intervention: Work-based mentoring programme (150 hours of mentored clinical practice)
Number of subjects: 720

Group type: COMPARATOR
Intervention: Usual in-service training
Number of subjects: 720
Study: 22455972

Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation (PMR) training for 12 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Depot leuprolide, 11.25mg IM (both groups)
Number of subjects: 100
Study: 21516735

Group type: EXPERIMENTAL
Intervention: lornoxicam (8 or 12 mg/daily) for 15 days in addition to standard treatment
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: lornoxicam
Number of subjects: 85
Study: 17122979

Group type: EXPERIMENTAL
Intervention: Distributed training on 3 consecutive days (group A)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Distributed training within 1 day (group B)
Number of subjects: 20
Study: 16168782

Group type: EXPERIMENTAL
Intervention: Zinc (70 mg) weekly for 12 months
Number of subjects: 1665
Study: 11935032

Group type: EXPERIMENTAL
Intervention: CD14 C(‐260)T gene polymorphism
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: CD18 codon 441 gene polymorphism
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Dominant or recessive model
Number of subjects: 338

Group type: EXPERIMENTAL
Intervention: Subgroup analysis restricted to thromboembolic events
Number of subjects: 338
Study: 9950944

Group type: EXPERIMENTAL
Intervention: Eccentric training for 6 weeks
Number of subjects: 9

Group type: COMPARATOR
Intervention: Concentric training for 6 weeks
Number of subjects: 9
Study: 7646769

Group type: EXPERIMENTAL
Intervention: Paternal mononuclear cell immunization before conception
Number of subjects: 200

Group type: COMPARATOR
Intervention: Paternal mononuclear cell immunization after conception
Number of subjects: 200
Study: 2486813

Group type: EXPERIMENTAL
Intervention: Essential phospholipid choline capsules (EPLC) for a six weeks period
Number of subjects: 46

Group type: COMPARATOR
Intervention: Vitamin B complex capsules
Number of subjects: 46
Study: 1007830

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg perorally
Number of subjects: 14

Group type: COMPARATOR
Intervention: Atropine sulphate infusion
Number of subjects: 14
Study: 30762318

Group type: EXPERIMENTAL
Intervention: Mirror Therapy (MT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Phantom Exercises (PE)
Number of subjects: 40
Study: 28790141

Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanate (40/5.7 mg/kg per day)
Number of subjects: 319

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 319
Study: 25872631

Group type: EXPERIMENTAL
Intervention: Mouthwash containing high-molecular-weight component of cranberry (3 mg/ml)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo mouthwash (control)
Number of subjects: 20
Study: 23409801

Group type: EXPERIMENTAL
Intervention: Combined training group (5 sets at 5-8 RM half-squats with sprints between each set)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Combined training group
Number of subjects: 26
Study: 21641580

Group type: EXPERIMENTAL
Intervention: Internet guided self-help treatment programme based on CBT for 6 months with a 6-month follow-up
Number of subjects: 74

Group type: COMPARATOR
Intervention: Waiting list control for 6 months before intervention
Number of subjects: 74
Study: 19799568

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment in non-VA EDs
Number of subjects: 959

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment in VA EDs
Number of subjects: 959
Study: 17038141

Group type: EXPERIMENTAL
Intervention: Verapamil 240 mg daily in three divided doses for 3 days before cardioversion and 1 week after
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Verapamil 240 mg daily
Number of subjects: 23

Group type: COMPARATOR
Intervention: Usual medication (Control)
Number of subjects: 23
Study: 14764444

Group type: EXPERIMENTAL
Intervention: Dodecanoic acid (C12)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Decanoic acid (C10)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 0
Study: 11043499

Group type: EXPERIMENTAL
Intervention: Cyclosporine-A plus prednisone
Number of subjects: 18

Group type: COMPARATOR
Intervention: Oral prednisone alone
Number of subjects: 18
Study: 9294380

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Systemic behavior family therapy (SBFT)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Individual nondirective supportive therapy (NST)
Number of subjects: 107